Clinical uses of interferons
- 7 December 2007
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (2), 158-162
- https://doi.org/10.1111/j.1365-2125.2007.03055.x
Abstract
Interferons were first described by Isaacs & Lindenmann working at the National Institute for Medical Research, Mill Hill in 1957. Thus, the fiftieth year of their discovery is being celebrated this year at Oxford in a meeting of the International Society for Interferon and Cytokine Research. This then is an appropriate time to review the clinical applications of the interferons. To accomplish this coherently it is necessary also to review briefly what led to the discovery of interferons, why their clinical applications were so slow in coming, and the impact of interferon research on the biomedical sciences.This publication has 39 references indexed in Scilit:
- Peginterferon and Ribavirin for Chronic Hepatitis CThe New England Journal of Medicine, 2006
- Renal-Cell CarcinomaThe New England Journal of Medicine, 2005
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BThe New England Journal of Medicine, 2004
- Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2001
- Use of interferon-α in laryngeal papillomatosis: eight years of the Cuban national programmeThe Journal of Laryngology & Otology, 1997
- Synthesis in E. coli of a polypeptide with human leukocyte interferon activityNature, 1980
- Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1978
- INTERFERON TREATMENT OF DENDRITIC KERATITISThe Lancet, 1976
- Interferon produced by Cultures of Calf Kidney CellsNature, 1959
- An interference phenomenon in relation to yellow fever and other virusesThe Journal of Pathology and Bacteriology, 1937